| abstract |
Provided are activated insulin, a compound Momordica charantia peptide oral medicine for the treatment of diabetes, and a preparation method, comprising in parts by weight: 20-30 parts of Momordica charantia peptide, 4-6 parts of Panax quinquefolius, 10-12 parts of Astragalus, 3-5 parts of Ganoderma powder, 8-10 parts of Dioscorea polystachya powder, 10-15 parts of wheat bran, 10-12 parts of Psidium guajava leaf powder, 5-10 parts of onion extract, 5-10 parts of Lycium chinense, 12-15 parts of Gynura procumbens extract, 1-2 parts of Coix lacryma-jobi, 5-8 parts of konjac glucomannan, 8-10 parts of Nelumbo nucifera leaf, and 5-8 parts of xylooligosaccharides. The Momordica charantia peptide extraction process can increase the content of the Momordica charantia peptide active ingredient. |